Michael Lock

Michael Lock

Western University Canada - London / Canada
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 4977276
University of Western Ontario
person_outline Michael Lock's MOST POPULAR ARTICLES
1-) Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trialDA Palma, R Olson, S Harrow, S Gaede, AV Louie, C Haasbeek, L Mulroy, ...The Lancet 393 (10185), 2051-2058, 201915702019
2-) Stereotactic ablative radiotherapy for the comprehensive treatment of oligometastatic cancers: long-term results of the SABR-COMET phase II randomized trialDA Palma, R Olson, S Harrow, S Gaede, AV Louie, C Haasbeek, L Mulroy, ...Journal of Clinical Oncology 38 (25), 2830, 20208352020
3-) Prediction of radiation pneumonitis by dose–volume histogram parameters in lung cancer—a systematic reviewG Rodrigues, M Lock, D D\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\'Souza, E Yu, J Van DykRadiotherapy and oncology 71 (2), 127-138, 20045352004
4-) External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative …TJ Whelan, JA Julian, TS Berrang, DH Kim, I Germain, AM Nichol, M Akra, ...The Lancet 394 (10215), 2165-2172, 20193822019
5-) Effect of standard vs dose-escalated radiation therapy for patients with intermediate-risk prostate cancer: the NRG oncology RTOG 0126 randomized clinical trialJM Michalski, J Moughan, J Purdy, W Bosch, DW Bruner, JP Bahary, ...JAMA oncology 4 (6), e180039-e180039, 20183442018